CNS Pharmaceuticals, Inc. short interest in 2026
In 2026, CNS Pharmaceuticals, Inc.'s disclosed short interest ran from 4.57% of shares outstanding on 15 Jan 2026 to 0.86% on 14 Aug 2026, a change of -3.71 percentage points. The year's high was 7.19% on 15 Apr 2026 and its low 0.86% on 14 Aug 2026, averaging 4.73% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.07 days on 27 Feb 2026. Full history: CNS Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 4.57% (15 Jan 2026)
- End of year
- 0.86% (14 Aug 2026)
- Change
- -3.71 pp
- High
- 7.19% (15 Apr 2026)
- Low
- 0.86% (14 Aug 2026)
- Average
- 4.73%
- Highest days to cover
- 3.07 (27 Feb 2026)
- SEC filings marked
- 3
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 4.57% | 1.00 | |
| 30 Jan 2026 | 4.91% | 1.00 | |
| 13 Feb 2026 | 6.67% | 1.62 | |
| 27 Feb 2026 | 7.00% | 3.07 | |
| 13 Mar 2026 | 6.03% | 1.00 | |
| 31 Mar 2026 | 6.66% | 1.25 | 10-K filed |
| 15 Apr 2026 | 7.19% | 1.89 | |
| 30 Apr 2026 | 4.80% | 2.10 | |
| 15 May 2026 | 3.77% | 1.00 | 10-Q filed |
| 29 May 2026 | 5.98% | 1.00 | |
| 15 Jun 2026 | 4.77% | 1.83 | |
| 30 Jun 2026 | 4.47% | 2.74 | |
| 15 Jul 2026 | 1.94% | 1.67 | |
| 31 Jul 2026 | 1.40% | 1.22 | |
| 14 Aug 2026 | 0.86% | 2.85 | 10-Q filed |
See also: CNS Pharmaceuticals, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.